PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19304526-6	2009	CONCLUSION: The inhibitory effect of celecoxib on Tca8113 cell growth and the expressions of VEGF-C and COX-2 may be related to the release of PGE2.	Dinoprostone	143-147	vascular endothelial growth factor C	Homo sapiens	93-99	
21577211-11	2011	Prostaglandin E(2) (PGE(2)) upregulated the expressions of VEGF-A and VEGF-C in cultured macrophages, but not human lymphatic microvascular endothelial cells.	Dinoprostone	0-18	vascular endothelial growth factor C	Homo sapiens	70-76	
21577211-11	2011	Prostaglandin E(2) (PGE(2)) upregulated the expressions of VEGF-A and VEGF-C in cultured macrophages, but not human lymphatic microvascular endothelial cells.	Dinoprostone	20-26	vascular endothelial growth factor C	Homo sapiens	70-76	
19275959-9	2009	Prostaglandin E(2) (PGE(2)) enhanced the expression of VEGFA, VEGFB, and VEGFC, whereas an adenosine analog (5"-[N-ethylcarboxamido] adenosine [NECA]) increased VEGFA, VEGFC, and VEGFD expression.	Dinoprostone	0-18	vascular endothelial growth factor C	Homo sapiens	73-78	
19275959-9	2009	Prostaglandin E(2) (PGE(2)) enhanced the expression of VEGFA, VEGFB, and VEGFC, whereas an adenosine analog (5"-[N-ethylcarboxamido] adenosine [NECA]) increased VEGFA, VEGFC, and VEGFD expression.	Dinoprostone	0-18	vascular endothelial growth factor C	Homo sapiens	168-173	
18509974-5	2008	The expressions of VEGF-C protein were evaluated in MDA-MB-231 cells treated by PGE2 (1 microg/ml) and Trastuzumab (1 microg/ml), respectively.	Dinoprostone	80-84	vascular endothelial growth factor C	Homo sapiens	19-25	
18509974-11	2008	The expression of VEGF-C protein up-regulated by PGE2 treatment was decreased by Trastuzumab.	Dinoprostone	49-53	vascular endothelial growth factor C	Homo sapiens	18-24	
16570043-6	2006	EP1 as well as EP4 receptor antagonists inhibited VEGF-C production indicating the roles of EP1 and EP4 in VEGF-C upregulation by endogenous PGE2.	Dinoprostone	141-145	vascular endothelial growth factor C	Homo sapiens	50-56	
16570043-6	2006	EP1 as well as EP4 receptor antagonists inhibited VEGF-C production indicating the roles of EP1 and EP4 in VEGF-C upregulation by endogenous PGE2.	Dinoprostone	141-145	vascular endothelial growth factor C	Homo sapiens	107-113	
14744769-9	2004	At the mechanistic level, we found that COX-2 expression or prostaglandin E(2) (PGE(2)) treatment could activate the HER-2/Neu tyrosine kinase receptor through the EP(1) receptor-dependent pathway and that this activation was essential for VEGF-C induction.	Dinoprostone	60-78	vascular endothelial growth factor C	Homo sapiens	240-246